2014’s Expert Speakers include:

 Inna Ben-anat
Inna Ben-anat
Director, head of Qbd and product robustness
Teva
 Pedro Hernandez
Pedro Hernandez
Director of Quality by design
Merck Serono
 Mingzhong Li
Mingzhong Li
principal lecturer in the pharmaceutical technologies
De Montfort University
 Julian Morris
Julian Morris
Director
Centre for Process Analytics and Control Technology (CPACT)
 Alain Poncin
Alain Poncin
continous improvement manager
Octoplus (part of Dr Reddy's laboratories)
 Sushill Srivastava
Sushill Srivastava
Process Research and Development Director
Bristol-Myers Squibb
 Jesus Zurdo
Jesus Zurdo
Head of innovation, biopharma development
Lonza
 John Purves
John Purves
Former
EMEA
 Lawrence Yu
Lawrence Yu
Acting Director, Office of Pharmaceutical Science
FDA
 Peter Hamilton
Peter Hamilton
Senior PAt Scientist
GlaxoSmithKline
 David Gervais
David Gervais
Senior process Scientist
Public Health England
 flavien Susanne
flavien Susanne
Chemical engineer
Novartis
 Peter Boogaard
Peter Boogaard
CEO
Industrial Lab Automation

Maximise Production Efficiency, Reduce Production Cycle Time, Reduce Cost and Increase Product Quality with PAT and Quality by Design


Providing you with the essential info!

Regulatory insight: what are the expectations of regulators? What are the critical requirements in applications? How have the approaches of regulators changed over the evolution of PAT and QbD processes? Regulatory experts share their experiences with PAT and QbD and their perspective on the best approach to achieving a successful application.

PAT and QbD case studies: industry leaders share their experiences with integrating PAT and QbD into their production cycles. Looking at the challenges faced, the strategies implemented and the impact it’s had.

Continuous Manufacturing: evaluating the benefits of moving from batch to continuous processing. Gain insight into tool selection, placement and monitoring and how to deal with atypical results.

Data: how to use real-time data to make real-time decisions.

The integration of PAT into production cycles has been hindered largely due to the high cost of restructuring production lines, a lack of evidence on ROI and a fear of regulatory scrutiny. The 2015 PAT and Quality by Design conference addresses these issues head on by bringing regulatory experts and industry leaders together for an open and compelling discussion.

Key topics of 2015:

  • Interpreting and applying the regulatory guidelines
  • Understanding the requirements and expectations of regulators with submissions
  • Case studies of PAT and QbD implementation and its impact
  • Moving from batch to continuous processing
  • Determining your risk management strategies
  • How to make data-driven decisions



Download 2014 Agenda

No Brochure.

Resource Centre

Visit the Resource Center for complimentary industry related content!

Featured Content

Sponsorship Opportunity

Learn more about sponsor & exhibit opportunities

IDGA

Become a GHP Network Member and receive our newsletter!

Quick Links